Logging a Rosacea Trigger-Diary Entry
Short placeholder: one flushing episode is recorded right after exposure.
- 5: Entry fields (Placeholder: exposure, time, severity)
- <1 hr: Recall window (Placeholder logging guidance)
- Flush/Papule: Entry types (Placeholder categories tracked)
- Pattern data: Goal (Placeholder purpose note)
What gets logged
Placeholder: exposure type, timing, and flare severity noted.
Why single entries are not enough
Placeholder: one entry cannot confirm a real trigger pattern.
Placeholder tip: log every flare, not just bad ones.
Identifying the Dominant Trigger Across Entries
Short placeholder: repeated entries expose which exposure recurs most.
- 5: Candidate triggers (Placeholder tracked categories)
- 8+: Entries for confidence (Placeholder recommended minimum)
- % match: Pattern metric (Placeholder scoring method)
- Heat/Alcohol: Common dominant (Placeholder survey finding)
Counting recurring exposures
Placeholder: tally each trigger type across all logged entries.
Confidence rises with volume
Placeholder: more entries sharpen the dominant-trigger signal.
Placeholder tip: two weeks of logging is usually enough.
Classifying Rosacea Subtype Alongside Triggers
Short placeholder: clinician confirms subtype independent of triggers.
- 3: Subtypes tracked (Placeholder classification set)
- Flushing: ETR hallmark (Placeholder visible sign)
- Papules: Papulopustular sign (Placeholder visible sign)
- Thickening: Phymatous sign (Placeholder visible sign)
Why subtype matters
Placeholder: treatment differs sharply by rosacea subtype.
Overlap is common
Placeholder: patients can show more than one subtype at once.
Placeholder tip: reassess subtype at each visit.
Matching Trigger Pattern and Subtype to Therapy
Short placeholder: the matched treatment addresses the confirmed pathway.
- Brimonidine: Flushing therapy (Placeholder topical option)
- Ivermectin: Inflammatory therapy (Placeholder topical option)
- Laser: Phymatous therapy (Placeholder procedural option)
- Avoidance plan: Always included (Placeholder baseline step)
Matching logic
Placeholder: subtype picks the drug class, trigger picks avoidance steps.
When confidence is low
Placeholder: more diary entries requested before committing therapy.
Placeholder tip: match confidence above 70% before starting.
Combined Avoidance Plus Matched Therapy Outcome
Short placeholder: pairing both approaches outperforms either alone.
- ~25%: Avoidance alone (Placeholder estimated reduction)
- ~35%: Therapy alone (Placeholder estimated reduction)
- ~60–80%: Combined plan (Placeholder estimated reduction)
- Monthly: Review cadence (Placeholder follow-up interval)
Why combining works
Placeholder: avoidance lowers flare triggers while therapy treats pathway.
Ongoing adjustment
Placeholder: plan is revised as new diary entries arrive.
Placeholder tip: re-run matching after any subtype change.
Treatment branches by subtype